Aurobindo Pharma arm acquires non-oncology portfolio of Khandelwal Labs

Published 3 hours ago
Source: thehindu.com
Aurobindo Pharma arm acquires non-oncology portfolio of Khandelwal Labs
The business generated a turnover of ₹113.5 crore in 2024-25 with an EBITDA of ₹28.9 crore. It has around 470 people strong field force and more than 1,600 stockists and other distribution related infrastructure.

Categories

Business